{name}
{subtitle}
Sasanlimab (PF-06801591) in Combination With BCG or as Single Agent in Participants With High-Risk Non-Muscle Invasive Bladder Cancer
city
~16 mi. (Granollers, Spain, +153 more cities)
facility
Hospital General de Granollers
condition
Bladder Urothelial Carcinoma, +2 more conditions
drug
BCG solution, +1 more drug
A Study Comparing Atezolizumab (Anti PD-L1 Antibody) In Combination With Adjuvant Anthracycline/Taxane-Based Chemotherapy Versus Chemotherapy Alone In Patients With Operable Triple-Negative Breast Cancer
city
~26 mi. (Badalona, Spain, +383 more cities)
facility
Hospital Universitari Germans Trias i Pujol; Servicio de Oncologia
biomarker
ER Negative, +2 more biomarkers
drug
atezolizumab, +4 more drugs
drug type
chemotherapy, +1 more type
Perioperative Enfortumab Vedotin (EV) Plus Pembrolizumab (MK-3475) Versus Neoadjuvant Chemotherapy for Cisplatin-eligible Muscle Invasive Bladder Cancer (MIBC) (MK-3475-B15/ KEYNOTE-B15 / EV-304)
city
~26 mi. (Badalona, Spain, +93 more cities)
facility
Hospital Germans Trias i Pujol. ICO de Badalona ( Site 0658)
condition
Bladder Carcinoma, +1 more condition
drug
cisplatin, +4 more drugs
drug type
chemotherapy, +3 more types
Perioperative Pembrolizumab (MK-3475) Plus Cystectomy or Perioperative Pembrolizumab Plus Enfortumab Vedotin Plus Cystectomy Versus Cystectomy Alone in Cisplatin-ineligible Participants With Muscle-invasive Bladder Cancer (MK-3475-905/KEYNOTE-905/EV-303)
city
~26 mi. (Badalona, Spain, +163 more cities)
facility
Hosp. Gral. Universitari Germans Trias i Pujol ( Site 0675)
drug
cystectomy, +2 more drugs
drug type
chemotherapy, +3 more types
A Study Evaluating the Efficacy and Safety of Adjuvant Atezolizumab or Placebo and Trastuzumab Emtansine for Participants With HER2-Positive Breast Cancer at High Risk of Recurrence Following Preoperative Therapy
city
~26 mi. (Badalona, Spain, +260 more cities)
facility
Hospital Universitari Germans Trias i Pujol; Servicio de Oncologia
biomarker
ERBB2 Amplification, +1 more biomarker
drug type
immunotherapy, +1 more type
Study of Pembrolizumab Given Prior to Surgery and in Combination With Radiotherapy Given Post-surgery for Advanced Head and Neck Squamous Cell Carcinoma (MK-3475-689)
city
~26 mi. (Badalona, Spain, +150 more cities)
facility
Hospital Germans Trias i Pujol. ICO de Badalona ( Site 1204)
drug
cisplatin, +2 more drugs
drug type
chemotherapy, +2 more types
Study Of Venetoclax Tablet With Intravenous or Subcutaneous Azacitidine to Assess Change in Disease Activity In Adult Participants With Newly Diagnosed Higher-Risk Myelodysplastic Syndrome
city
~26 mi. (Badalona, Spain, +201 more cities)
facility
Hospital Universitario Germans Trias i Pujol /ID# 221274
drug
azacitidine, +1 more drug